These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 38505602)

  • 1. FSH induces EMT in ovarian cancer via ALKBH5-regulated Snail m6A demethylation.
    Xu X; Zhuang X; Yu H; Li P; Li X; Lin H; Teoh JP; Chen Y; Yang Y; Cheng Y; Chen W; Fu X
    Theranostics; 2024; 14(5):2151-2166. PubMed ID: 38505602
    [No Abstract]   [Full Text] [Related]  

  • 2. Follicle-stimulating hormone induced epithelial-mesenchymal transition of epithelial ovarian cancer cells through follicle-stimulating hormone receptor PI3K/Akt-Snail signaling pathway.
    Yang Y; Zhang J; Zhu Y; Zhang Z; Sun H; Feng Y
    Int J Gynecol Cancer; 2014 Nov; 24(9):1564-74. PubMed ID: 25340291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA demethylase ALKBH5 promotes ovarian carcinogenesis in a simulated tumour microenvironment through stimulating NF-κB pathway.
    Jiang Y; Wan Y; Gong M; Zhou S; Qiu J; Cheng W
    J Cell Mol Med; 2020 Jun; 24(11):6137-6148. PubMed ID: 32329191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ALKBH5 activates FAK signaling through m6A demethylation in
    Sun R; Yuan L; Jiang Y; Wan Y; Ma X; Yang J; Sun G; Zhou S; Wang H; Qiu J; Zhang L; Cheng W
    Theranostics; 2023; 13(2):833-848. PubMed ID: 36632222
    [No Abstract]   [Full Text] [Related]  

  • 5. ALKBH5-mediated m
    Hao L; Yin J; Yang H; Li C; Zhu L; Liu L; Zhong J
    Aging (Albany NY); 2021 Jan; 13(3):4045-4062. PubMed ID: 33428593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ALKBH5-HOXA10 loop-mediated JAK2 m6A demethylation and cisplatin resistance in epithelial ovarian cancer.
    Nie S; Zhang L; Liu J; Wan Y; Jiang Y; Yang J; Sun R; Ma X; Sun G; Meng H; Xu M; Cheng W
    J Exp Clin Cancer Res; 2021 Sep; 40(1):284. PubMed ID: 34496932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner.
    Guo X; Li K; Jiang W; Hu Y; Xiao W; Huang Y; Feng Y; Pan Q; Wan R
    Mol Cancer; 2020 May; 19(1):91. PubMed ID: 32429928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA demethylase ALKBH5 inhibits TGF-β-induced EMT by regulating TGF-β/SMAD signaling in non-small cell lung cancer.
    Sun Z; Su Z; Zhou Z; Wang S; Wang Z; Tong X; Li C; Wang Y; Chen X; Lei Z; Zhang HT
    FASEB J; 2022 May; 36(5):e22283. PubMed ID: 35344216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ALKBH5 Inhibits Pancreatic Cancer Motility by Decreasing Long Non-Coding RNA KCNK15-AS1 Methylation.
    He Y; Hu H; Wang Y; Yuan H; Lu Z; Wu P; Liu D; Tian L; Yin J; Jiang K; Miao Y
    Cell Physiol Biochem; 2018; 48(2):838-846. PubMed ID: 30032148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPV E7-drived ALKBH5 promotes cervical cancer progression by modulating m6A modification of PAK5.
    Huo FC; Zhu ZM; Du WQ; Pan YJ; Jiang X; Kang MJ; Liu BW; Mou J; Pei DS
    Pharmacol Res; 2023 Sep; 195():106863. PubMed ID: 37480971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OCT4 mediates FSH-induced epithelial-mesenchymal transition and invasion through the ERK1/2 signaling pathway in epithelial ovarian cancer.
    Liu L; Zhang J; Fang C; Zhang Z; Feng Y; Xi X
    Biochem Biophys Res Commun; 2015 Jun; 461(3):525-32. PubMed ID: 25911324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ALKBH5 inhibited autophagy of epithelial ovarian cancer through miR-7 and BCL-2.
    Zhu H; Gan X; Jiang X; Diao S; Wu H; Hu J
    J Exp Clin Cancer Res; 2019 Apr; 38(1):163. PubMed ID: 30987661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ALKBH5 regulates paclitaxel resistance in NSCLC via inhibiting CEMIP-mediated EMT.
    Gao L; Qiao L; Li Y; Jia L; Cui W; Yang J; Wu C; Wang L
    Toxicol Appl Pharmacol; 2024 Feb; 483():116807. PubMed ID: 38199493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of m6A mRNA modification by DNA hypermethylated ALKBH5 aggravates the oncological behavior of KRAS mutation/LKB1 loss lung cancer.
    Zhang D; Ning J; Okon I; Zheng X; Satyanarayana G; Song P; Xu S; Zou MH
    Cell Death Dis; 2021 May; 12(6):518. PubMed ID: 34016959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-translational modification of RNA m6A demethylase ALKBH5 regulates ROS-induced DNA damage response.
    Yu F; Wei J; Cui X; Yu C; Ni W; Bungert J; Wu L; He C; Qian Z
    Nucleic Acids Res; 2021 Jun; 49(10):5779-5797. PubMed ID: 34048572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The m6A demethylase ALKBH5 promotes tumor progression by inhibiting RIG-I expression and interferon alpha production through the IKKε/TBK1/IRF3 pathway in head and neck squamous cell carcinoma.
    Jin S; Li M; Chang H; Wang R; Zhang Z; Zhang J; He Y; Ma H
    Mol Cancer; 2022 Apr; 21(1):97. PubMed ID: 35395767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progranulin expression induced by follicle-stimulating hormone in ovarian cancer cell lines depends on the histological subtype.
    Perez-Juarez CE; Arechavaleta-Velasco F; Mendez C; Díaz-Cueto L
    Med Oncol; 2020 May; 37(7):59. PubMed ID: 32474861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demethylase ALKBH5 suppresses invasion of gastric cancer via PKMYT1 m6A modification.
    Hu Y; Gong C; Li Z; Liu J; Chen Y; Huang Y; Luo Q; Wang S; Hou Y; Yang S; Xiao Y
    Mol Cancer; 2022 Feb; 21(1):34. PubMed ID: 35114989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ALKBH5-Mediated m6A Demethylation of GLUT4 mRNA Promotes Glycolysis and Resistance to HER2-Targeted Therapy in Breast Cancer.
    Liu H; Lyu H; Jiang G; Chen D; Ruan S; Liu S; Zhou L; Yang M; Zeng S; He Z; Wang H; Li H; Zheng G; Liu B
    Cancer Res; 2022 Nov; 82(21):3974-3986. PubMed ID: 36069931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA demethylase ALKBH5 promotes colorectal cancer progression by posttranscriptional activation of RAB5A in an m6A-YTHDF2-dependent manner.
    Shen D; Lin J; Xie Y; Zhuang Z; Xu G; Peng S; Tang G; Bai L; Zhu M; Zhang Y; Huang Z; Wang P; Liu X; Huang M; Luo Y; Wang X; Yu H
    Clin Transl Med; 2023 May; 13(5):e1279. PubMed ID: 37203239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.